Saudi Arabia
+918770708752

Unicristin Injection Supply in Riyadh for Oncology Treatment Networks

A Riyadh oncology network cannot safely evaluate Unicristin from a brand name and a 1 mg strength alone. Buyers need to confirm the exact presentation, Saudi regulatory status, clinical-use safeguards, cold-chain evidence, and commercial terms before accepting a quotation or placing a wholesale order.

Key takeaways

  • Match Unicristin 1 mg to the Saudi-approved label and physical vial pack.
  • Treat vincristine as a protocol medicine, not an isolated oncology purchase.
  • Request SFDA registration, importer eligibility, batch documents, and a certificate of analysis.
  • Pilot one validated shipment before approving network-wide vincristine injection volume.

Confirm what Unicristin 1 mg actually contains and how it is presented

Ask for the registered product identity, not just “Unicristin 1 mg.” Unicristin is a brand name for vincristine sulfate, and “1 mg” could describe total content rather than concentration. The quotation must match the Saudi-approved label and the physical pack.

  1. Active ingredient: vincristine sulfate; state the strength as both concentration and total amount, such as 1 mg/mL and 1 mg in 1 mL.
  2. Presentation: confirm whether it is a single-dose vial or ampoule, the fill volume, stopper or seal, and the exact approved label wording.
  3. Pack specification: state the number of containers per carton, preservative status, storage instruction, and minimum remaining shelf life on arrival.
  4. Manufacturer record: request the manufacturer, manufacturing site, country of manufacture, marketing-authorisation holder, and Saudi registration number or documented exemption basis.
  5. Batch evidence: require the batch number, expiry date, certificate of analysis, batch-release certificate, current label or package photograph, and shipment temperature records.

A listing from a “Unicristin injection supplier in Riyadh” is not comparable with another offer until these fields match. A vincristine sulfate injection supplier offering ordinary ambient-temperature stock must provide product-specific stability data or an approved excursion assessment; the normal instruction is refrigerated storage at 2–8 °C with protection from light.

Compare 1 mg/1 mL, 2 mg/2 mL, and 5 mg/5 mL as different presentations, not interchangeable descriptions.

Place vincristine within the oncology protocol, not beside it

Vincristine is a protocol component, not a standalone “oncology injection.” It is a vinca alkaloid used in regimen-specific combinations, with dosing generally calculated from body-surface area and adjusted or withheld for neurotoxicity, hepatic dysfunction, or interacting medicines. A 1 mg vial is a supply unit, never a default patient dose.

Before pharmacy releases a dose, the treating oncology team must confirm the diagnosis, protocol day, calculated dose, maximum-dose rule where the protocol specifies one, and the patient’s liver function and neurological baseline.

The pharmacist must also screen the medication list: strong CYP3A inhibitors, including azole antifungals and some macrolides, can raise vincristine exposure and worsen toxicity.

Use a documented pre-administration check:

  • Match the vial, concentration, batch number, expiry date, label and preparation instructions to the approved protocol.
  • For Riyadh use, verify the exact presentation in Saudi Food and Drug Authority registered-drug resources.
  • Confirm the route is intravenous only; intrathecal administration is a fatal medication error.
  • Require an independent check of patient identity, dose calculation, dilution, route and administration time.
  • Inspect the container for leaks, cracks, particles or discolouration, and verify storage and transport records.
  • Confirm venous access because vincristine is a vesicant; extravasation can cause severe tissue injury.
  • Record neuropathy, constipation or ileus, weakness and other toxicity findings before administration.

A supplier can provide product and batch evidence, but it cannot replace the treating team’s clinical decision.

Build a Riyadh wholesale quotation around documents and legal eligibility

A quotation is not orderable until the product and both sides of the transaction are legally identifiable. Check the exact Unicristin presentation in the Saudi Food and Drug Authority’s registered-drug resources, then record its registration status, marketing-authorisation holder, manufacturer, manufacturing site and Saudi-licensed importer.

An overseas export licence alone does not permit supply to a Riyadh hospital.

Before comparing vincristine injection wholesale offers, request:

  • A current label or package photograph showing vincristine sulfate, concentration, total quantity, dosage form, preservative status and approved wording.
  • A certificate of analysis, batch-release certificate, batch number, expiry date, country of manufacture and storage range.
  • A pro forma invoice stating pack size, available shelf life on arrival, minimum order quantity, lead time, Incoterm, payment terms and delivery address.
  • The Saudi importer’s licence and the buyer’s healthcare or wholesale licence, plus any registration or exemption document used for the shipment.
Buyer typeEligibility to confirmQuotation evidence
HospitalFacility licence and authorised pharmacy purchaserPurchase order, delivery site and tender code
ClinicLicensed facility and oncology-pharmacy authorityNamed prescriber or pharmacist and intended quantity
DistributorSaudi wholesale licence and approved storage facilityResale authorisation, territory and stock commitment
Tender bidderTender registration and product eligibilityValid registration, validity period and required bonds

NIBA HEALTHCARE may be assessed as an Indian source, but Indian manufacturing approval, GMP certification or export history does not replace Saudi registration or a legally responsible local importer. Reject any offer that quotes only “1 mg” without stating concentration, fill volume and containers per pack.

Related product

UNICRISTIN INJECTION 1 MG

VINCRISTINE SULFATE INJECTION USP

UNICRISTIN INJECTION 1 MG

Unicristin 1mg Injection is an anti-cancer medication used in the treatment of breast cancer, non-small cell lung cancer, pancreatic cancer, kidney...

View product →

Test cold-chain control, hazardous-drug handling, and batch traceability

A suitable vincristine injection shipment has a documented temperature history, intact packaging, and an unbroken batch trail from release to receipt. “Kept refrigerated” is not evidence.

Ask an oncology injection supplier in Riyadh for these records before accepting delivery:

  • A calibrated data-logger report covering dispatch, transit, customs, and receipt; compare every reading with the product label’s storage range and check for freezing or unexplained gaps.
  • The certificate of analysis, batch-release certificate, batch number, expiry date, and manufacturing-site details; every identifier must match the vial, carton, invoice, and shipping documents.
  • The current approved label, showing storage instructions, light protection, container type, and any single-dose or preservative statement.
  • A signed temperature-excursion assessment if the logger records a deviation; do not use the stock until the manufacturer or authorised quality unit gives a written disposition.
  • Saudi drug track-and-trace or serialisation data where applicable, plus recall contacts and a process for confirming affected packs within hours.
  • Evidence that the receiving pharmacy follows hazardous-drug procedures for unloading, quarantine, storage, spill response, preparation, administration, and waste; USP <800> and NIOSH hazardous-drug controls provide recognised reference points.

At receipt, inspect the seal, carton, vial, label legibility, leakage, crystals, and visible particles. Record who received each batch and its storage temperature. Verify the product and legally responsible importer through Saudi Food and Drug Authority resources; an overseas export licence alone does not establish Saudi supply eligibility.

Use a staged sourcing workflow before committing network-wide volume

Do not award network-wide volume from a low unit price. Run a documented pilot with each shortlisted supplier, then expand only after the first shipment passes pharmacy, quality, and logistics checks.

  1. Send every supplier the same specification: Unicristin 1 mg presentation, fill volume, container count, preservative status, storage range, required remaining shelf life, destination, and monthly demand.
  2. Request a current label or package photograph, certificate of analysis, batch-release certificate, Saudi registration or exemption basis, and transport temperature records before issuing a purchase order.
  3. Place a controlled first order for one or two batches, with agreed delivery dates, minimum remaining shelf life, temperature-excursion notification, damaged-container replacement, and recall support.
  4. Have the oncology pharmacy inspect seals, labels, vials, batch numbers, expiry dates, shipment temperature data, and Saudi traceability records before accepting stock.
  5. Compare the received batch against the quotation, purchase order, and documents. Escalate discrepancies before increasing volume.
Supplier stageEvidence to compareDecision
Quotation reviewComplete specification, registration basis, price, lead time, MOQ, payment and replacement termsShortlist only if no critical field is missing
Pilot shipmentIntact containers, in-range transport record, acceptable shelf life and matching batch documentsAccept, quarantine, or reject
Network rolloutRepeat delivery performance, batch traceability, recall response and stock continuityApprove volume or retain backup supplier

A quotation is operationally usable only when it identifies the exact registered presentation and assigns responsibility for an excursion, shortage, damaged vial, or batch recall. Keep a second qualified source until repeated deliveries prove reliable.

Frequently asked questions

  • What should you confirm about Unicristin 1 mg injection?

    Confirm that the registered product contains vincristine sulfate, then match its total content, concentration, vial presentation, label, and pack size to the Saudi-approved product.

  • How should vincristine sulfate injection be evaluated within an oncology network?

    Evaluate it against the treatment protocols that use vincristine, including regimen timing, dose calculation, compatible presentation, administration controls, and the network’s oncology pharmacy procedures.

  • Which documents belong in a Riyadh wholesale quotation?

    Request the Saudi-approved product identity, SFDA registration evidence, the supplier’s legal eligibility to supply medicines, batch-specific certificate of analysis, expiry details, and shipping documentation.

  • How can a buyer test vincristine injection supply before placing a large order?

    Use a staged workflow: verify the supplier and product, review documents, inspect cold-chain and hazardous-drug controls, receive a pilot shipment, reconcile batch records, and expand only after acceptance.

 2026-09-29T13:00:15

Keywords